Topic: Individualized Treatment

Provider Involvement in Care During Initial Cancer Treatment and Patient Preferences for Provider Roles After Initial Treatment

Radhakrishnan A, Li Y, Furgal AKC, Hamilton AS, Ward KC, Jagsi R, Katz SJ, Hawley ST, Wallner LP. JCO. 2019;15(4):e328-e337.

Patient Views and Correlates of Radiotherapy Omission in a Population-Based Sample of Older Women with Favorable Prognosis Breast Cancer

Shumway DA, Griffith KA, Hawley ST, Wallner LP, Ward KC, Hamilton AS, Morrow M, Katz SJ, Jagsi R. Cancer 1 July 2018;124(13):2714-2723.

Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer

Kurian AW, Ward KC, Hamilton AS, Deapen DM, Abrahamse P, Bondarenko I, Li Y, Hawley ST, Morrow M, Jagsi R, Katz SJ. JAMA Oncol 2018 August 1;4(8):1066-1072.

Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer

Katz SJ, Ward KC, Hamilton AS, McLeod MC, Wallner LP, Morrow M, Jagsi R, Hawley ST, Kurian AW. J Clin Oncol 20 April 2018;36(12):1218-1224.

Reducing Overtreatment of Cancer With Precision Medicine: Just What the Doctor Ordered

Katz SJ, Jagsi R, Morrow M. JAMA 20 March 2018;319(11):1091-1092.

Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy For Women With Breast Cancer

Katz SJ, Hawley ST, Hamilton AS, Ward KC, Morrow M, Jagsi R, Hofer TP. JAMA Surg. 1 January 2018;153(1):29-36.

Treatment decisions and employment of breast cancer patients: Results of a population-based survey

Jagsi R, Abrahamse PH, Lee KL, Wallner LP, Janz NK, Hamilton AS, Ward KC, Morrow M, Kurian AW, Friese CR, Hawley ST. and Katz SJ. Cancer. 2017 December 15;123(24):4791-4799.

Trends in Reoperation After Initial Lumpectomy for Breast Cancer: Addressing Overtreatment in Surgical Management

Morrow M, Abrahamse P, Hofer TP, Ward KC, Hamilton AS, Kurian AW, Katz SJ, Jagsi R. JAMA Oncol 1 October 2017;3(10):1352-1357.

The association between patient attitudes and values and the strength of consideration for contralateral prophylactic mastectomy in a population-based sample of breast cancer patients

Hawley ST, Griffith KA, Hamilton AS, Ward KC, Morrow M, Janz NK, Katz SJ, Jagsi R. Cancer. 2017 Dec 1;123(23):4547-4555.

Oncologists’ influence on receipt of adjuvant chemotherapy: does it matter whom you see for treatment of curable breast cancer?

Katz SJ, Hawley ST, Bondarenko I, Jagsi R, Ward KC, Hofer TP, Kurian AW. Breast Cancer Res Treat (2017) 165: 751-756.

Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer

Kurian AW, Li Y, Hamilton AS, Ward KC, Hawley ST, Morrow M, McLeod MC, Jagsi R, Katz SJ. J Clin Oncol July 2017; 35:20, 2232-2239.

Patient Reactions to Surgeon Recommendations About Contralateral Prophylactic Mastectomy for Treatment of Breast Cancer

Katz SJ, Janz NK, Abrahamse P, Wallner LP, Hawley ST, An LC, Ward KC, Hamilton AS, Morrow M, Jagsi R. JAMA Surg 2017 July 1;152(7):658-664.

Surgeon Attitudes and Use of MRI in Patients Newly Diagnosed with Breast Cancer

Morrow M, Hawley ST, McLeod MC, Hamilton AS, Ward KC, Katz SJ, Jagsi R. Ann Surg Oncol Jul 2017; 24(7):1889-1896.

Treatment-associated toxicities reported by patients with early-stage invasive breast cancer

Friese CR, Harrison JM, Janz NK, Jagsi R, Morrow M, Li Y, Hamilton AS, Ward KC, Kurian AK, Katz SJ, Hofer TP. Cancer Jun 2017; 123(11):1925-1934.

Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer

Jagsi R, Hawley ST, Griffith KA, Janz NK, Kurian AW, Ward KC, Hamilton AS, Morrow M, Katz SJ. JAMA Surg Mar 2017; 152(3):274-282.

Second Opinions From Medical Oncologists for Early-Stage Breast Cancer: Prevalence, Correlates, and Consequences

Kurian AW, Friese CR, Bondarenko I, Jagsi R, Li Y, Hamilton AS, Ward KC, Katz SJ. JAMA Oncol Mar 2017; 3(3):391-397.

Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer

Kurian AW, Griffith KA, Hamilton AS, Ward KC, Morrow M, Katz SJ, Jagsi R. JAMA Feb 2017; 317(5):531-534.

The influence of 21-gene recurrence score assay on chemotherapy use in a population-based sample of breast cancer patients

Li Y, Kurian AW, Bondarenko I, Taylor JM, Jagsi R, Ward KC, Hamilton AS, Katz SJ, Hofer TP. Breast Cancer Res Treat Feb 2017; 161(3):587-595.

Chemotherapy Decisions and Patient Experience With the Recurrence Score Assay for Early-Stage Breast Cancer

Friese CR, Li Y, Bondarenko I, Hofer TP, Ward KC, Hamilton AS, Deapen D, Kurian AW, Katz SJ. Cancer Jan 2017; 123(1):43-51.

Discordance between original and central laboratories in ER and HER2 results in a diverse, population-based sample

Griggs JJ, Hamilton AS, Schwartz KL, Zhao W, Abrahamse PH, Thomas DG, Jorns JM, Jewell R, Saber ME, Haque R, Katz SJ. Breast Cancer Res Treat Jan 2017; 161(2):375-384.

Treatment Decision Making and Genetic Testing for Breast Cancer: Mainstreaming Mutations

Katz SJ, Kurian A, Morrow M. JAMA 2015 Sep 8; 314(10):997-8.

Concerns About Cancer Risk and Experiences With Genetic Testing in a Diverse Population of Patients With Breast Cancer.

Jagsi R, Griffith K, Kurian A, Morrow M, Hamilton A, Graff J, Katz S, Hawley S. J Clin Oncol 2015 Apr 6; 33(14): 1584-91.

Development and psychometric properties of a brief measure of subjective decision quality for breast cancer treatment.

Resnicow K, Abrahamse P, Tocco RS, Hawley S, Griggs J, Janz N, Fagerlin A, Wilson A, Ward KC, Gabram SG, Katz SJ. BMC Med Inform Decis Mak 2014; 14:110.

Access to breast reconstruction after mastectomy and patient perspectives on reconstruction decision making.

Morrow M, Li Y, Alderman AK, Jagsi R, Hamilton AS, Graff JJ, Hawley ST, Katz SJ. JAMA Surg 2014; 149(10): 1015-21.

Social and clinical determinants of contralateral prophylactic mastectomy.

Hawley ST, Jagsi R, Morrow M, Janz NK, Hamilton A, Graff JJ, Katz SJ. JAMA Surg 2014; 149(6):582-589.

Providers of follow-up care in a population-based sample of breast care survivors.

Friese CR, Martinez KA, Abrahamse P, Hamilton AS, Graff JJ, Jagsi R, Griggs JJ, Hawley ST, Katz SJ. Breast Cancer Res Treat 2014; 144(1):179-84.

The value of sharing treatment decision-making with patients: are we expecting too much?

Katz SJ, Hawley ST. JAMA 2013; 310(15): 1559-1560.

Adjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast cancer.

Friese CR, Pini TM, Li Y, Abrahamse PH, Graff JJ, Hamilton AS, Jagsi R, Janz NK, Hawley ST, Katz SJ, Griggs JJ. Breast Cancer Res Treat 2013; 138(3):931-9.

Surgeon recommendations and receipt of mastectomy for treatment of breast cancer.

Morrow M, Jagsi R, Alderman AK, Griggs JJ, Hawley ST, Hamilton AS, Graff JJ, Katz SJ. JAMA 2009; 302(14): 1551-1556.

Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients.

Hawley ST, Hamilton AS, Graff JJ, Janz NK, Griggs JJ, Morrow M, Jagsi R, Salem B, Katz SJ. J Nat Cancer Inst 2009; 101(19): 1337-1447.

Symptom Experience and Quality of Life of Women Following Breast Cancer Treatment.

Janz NK, Mujahid M, Chung LK, Lantz PM, Fagerlin A, Hawley ST, Morrow M, Schwartz K, Katz SJ. J Womens Health 2007; 16(9): 1348-1361.

Patient satisfaction with the treatment of breast cancer: does surgeon specialization matter?

Waljee JF, Hawley ST, Alderman AK, Morrow M, Katz SJ. J Clin Oncol 2007; 25(24): 3694-3698.